-
1
Maximum Somatic Allele Frequency in Combination With Blood-Based Tumor Mutational Burden to Predict the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer: A Pooled An...
Published 2019-12-01Subjects: “…maximum somatic allele frequency (MSAF)…”
Get full text
Article -
2
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
Published 2018-11-01Subjects: Get full text
Article